Comparing the effectiveness of stimulation using rhTSH and thyroid hormone withdrawal in the treatment of thyroid cancer.

about

Comparing the effectiveness of stimulation using rhTSH and thyroid hormone withdrawal in the treatment of thyroid cancer.

Item

http://www.wikidata.org/entity/Q45977788

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Comparing the effectiveness of ...... e treatment of thyroid cancer.

@en

Comparing the effectiveness of ...... e treatment of thyroid cancer.

@nl

type

Item

label

Comparing the effectiveness of ...... e treatment of thyroid cancer.

@en

Comparing the effectiveness of ...... e treatment of thyroid cancer.

@nl

prefLabel

Comparing the effectiveness of ...... e treatment of thyroid cancer.

@en

Comparing the effectiveness of ...... e treatment of thyroid cancer.

@nl

P1476

Comparing the effectiveness of ...... e treatment of thyroid cancer.

@en

P2860

Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer.

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.

The carcinogenic effects of radioiodine therapy for thyroid carcinoma.

Five-year survival is similar in thyroid cancer patients with distant metastases prepared for radioactive iodine therapy with either thyroid hormone withdrawal or recombinant human TSH.

High-risk patients with differentiated thyroid cancer T4 primary tumors achieve remnant ablation equally well using rhTSH or thyroid hormone withdrawal.

The increasing incidence of small thyroid cancers: where are the cases coming from?

rhTSH stimulation before radioiodine therapy in thyroid cancer reduces the effective half-life of (131)I.

Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal.

Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?

Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients.

P2888

1756-6614-8-s1-a16

P304

A16-A16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1756-6614-8-S1-A16

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Aldona Kowalska

P577

2015-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1000322037

http://www.w3.org/2001/XMLSchema#string

P932

4480962

http://www.w3.org/2001/XMLSchema#string